SANDOSTATIN LAR: 400 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
400
Total FAERS Reports
158 (39.5%)
Deaths Reported
171
Hospitalizations
400
As Primary/Secondary Suspect
9
Life-Threatening
13
Disabilities
First Report: 1997 · Latest Report: 20140626
What Are the Most Common SANDOSTATIN LAR Side Effects?
#1 Most Reported
Death
117 reports (29.3%)
#2 Most Reported
Malaise
49 reports (12.3%)
#3 Most Reported
Diarrhoea
49 reports (12.3%)
All SANDOSTATIN LAR Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 117 | 29.3% | 117 | 37 |
| Diarrhoea | 49 | 12.3% | 19 | 24 |
| Malaise | 49 | 12.3% | 19 | 30 |
| Asthenia | 45 | 11.3% | 25 | 32 |
| Malignant neoplasm progression | 45 | 11.3% | 30 | 20 |
| Nausea | 37 | 9.3% | 16 | 26 |
| Weight decreased | 37 | 9.3% | 19 | 26 |
| Fatigue | 36 | 9.0% | 19 | 22 |
| Pain | 34 | 8.5% | 10 | 22 |
| Vomiting | 31 | 7.8% | 15 | 23 |
| Dyspnoea | 29 | 7.3% | 15 | 23 |
| Blood pressure increased | 26 | 6.5% | 19 | 15 |
| Dizziness | 24 | 6.0% | 7 | 15 |
| Abdominal pain | 23 | 5.8% | 10 | 15 |
| Decreased appetite | 21 | 5.3% | 10 | 14 |
| Fall | 21 | 5.3% | 8 | 16 |
| Drug ineffective | 19 | 4.8% | 6 | 6 |
| Pain in extremity | 19 | 4.8% | 10 | 10 |
| Back pain | 18 | 4.5% | 10 | 11 |
| Injection site pain | 18 | 4.5% | 12 | 9 |
Who Reports SANDOSTATIN LAR Side Effects? Age & Gender Data
Average age: 63.0 years. Most reports from: COUNTRY NOT SPECIFIED. View detailed demographics →
Is SANDOSTATIN LAR Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2005 | 1 | 0 | 0 |
| 2007 | 1 | 1 | 1 |
| 2008 | 1 | 0 | 0 |
| 2009 | 3 | 0 | 1 |
| 2010 | 7 | 3 | 4 |
| 2011 | 13 | 5 | 8 |
| 2012 | 24 | 8 | 15 |
| 2013 | 104 | 48 | 54 |
| 2014 | 106 | 53 | 49 |
What Is SANDOSTATIN LAR Used For?
| Indication | Reports |
|---|---|
| Acromegaly | 86 |
| Neuroendocrine tumour | 82 |
| Off label use | 45 |
| Carcinoid tumour | 34 |
| Carcinoid syndrome | 31 |
| Pancreatic neuroendocrine tumour | 25 |
| Diarrhoea | 6 |
| Meningioma | 6 |
| Endocrine neoplasm | 5 |
| Metastatic carcinoid tumour | 5 |
SANDOSTATIN LAR vs Alternatives: Which Is Safer?
SANDOSTATIN LAR vs SANDOZ FENTANYL SYSTEM
SANDOSTATIN LAR vs SAPROPTERIN
SANDOSTATIN LAR vs SAQUINAVIR
SANDOSTATIN LAR vs SARECYCLINE
SANDOSTATIN LAR vs SARGRAMOSTIM
SANDOSTATIN LAR vs SARILUMAB
SANDOSTATIN LAR vs SATRALIZUMAB
SANDOSTATIN LAR vs SATRALIZUMAB-MWGE
SANDOSTATIN LAR vs SAXAGLIPTIN
SANDOSTATIN LAR vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER
Official FDA Label for SANDOSTATIN LAR
Official prescribing information from the FDA-approved drug label.